World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
29269
World Ranking
14064
National Ranking
7135

Celina G. Kleer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Celina G. Kleer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 241 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Celina G. Kleer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Celina G. Kleer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Celina G. Kleer is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans multiple areas within biochemistry, genetics, molecular biology, and medicine.

Their work predominantly focuses on the following fields of study:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Kleer has contributed extensively to several subfields, including:

  • Molecular Biology
  • Cancer Research
  • Oncology
  • Biomedical Engineering
  • Genetics

The main research topics covered in their publications include:

  • Epigenetics and DNA Methylation
  • Cancer Cells and Metastasis
  • RNA modifications and cancer
  • Breast Cancer Treatment Studies
  • Nanoplatforms for cancer theranostics
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism

Celina G. Kleer has published numerous papers, with several recent notable ones listed below:

  • Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors, 2020, Nature Communications
  • Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice, 2020, Journal of Clinical Investigation
  • Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression, 2022, Nature Communications
  • Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer, 2021, American Journal Of Pathology
  • Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic, 2024, EBioMedicine

The scientist frequently publishes in the following venues:

  • Cancer Research
  • Nature Communications
  • EBioMedicine
  • Advanced Healthcare Materials
  • Applied immunohistochemistry & molecular morphology

Celina G. Kleer has collaborated extensively with several co-authors, including:

  • Maria E. González
  • Ahmad Eido
  • Sabra Djomehri
  • Sebastiano Andò
  • Shilpa R. Tekula

Best Publications

  • ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

    Christophe Ginestier;Min Hee Hur;Emmanuelle Charafe-Jauffret;Florence Monville

  • EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

    Celina G. Kleer;Qi Cao;Sooryanarayana Varambally;Ronglai Shen

  • Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity

    Christine L. Chaffer;Nemanja D. Marjanovic;Tony Lee;George Bell

  • CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature

    Zhenhua Miao;Kathryn E. Luker;Bretton C. Summers;Rob Berahovich

  • Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks

    Suling Liu;Christophe Ginestier;Sing J. Ou;Shawn G. Clouthier

  • Repression of E-cadherin by the polycomb group protein EZH2 in cancer

    Qi Cao;J. Yu;S. M. Dhanasekaran;J. H. Kim

  • BRCA1 regulates human mammary stem/progenitor cell fate

    Suling Liu;Christophe Ginestier;Emmanuelle Charafe-Jauffret;Hailey Foco

  • E-cadherin expression in primary carcinomas of the breast and its distant metastases.

    Paul J Kowalski;Mark A Rubin;Celina G Kleer

  • Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

    Quintin Pan;Celina G. Kleer;Kenneth L. Van Golen;Jennifer Irani

  • Discoidin domain receptor tyrosine kinases: new players in cancer progression.

    Rajeshwari R. Valiathan;Marta Marco;Birgit Leitinger;Celina G. Kleer

  • Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

    Dan R. Robinson;Shanker Kalyana-Sundaram;Shanker Kalyana-Sundaram;Yi Mi Wu;Sunita Shankar

  • Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.

    Ming Zhou;Arul M. Chinnaiyan;Celina G. Kleer;Peter C. Lucas

  • Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysis

    Rohit Mehra;Sooryanarayana Varambally;Lei Ding;Ronglai Shen

  • Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression

    Zhao Qiu Wu;Xiao Yan Li;Casey Yuexian Hu;Michael Ford

  • An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers

    Agnieszka K. Witkiewicz;Abhijit Dasgupta;Federica Sotgia;Isabelle Mercier

  • Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast

    Susan C. Lester;Shikha Bose;Yunn Yi Chen;James L. Connolly

  • Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board

    Erika A. Newman;Amy B. Guest;Mark A. Helvie;Marilyn A. Roubidoux

  • Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer

    Wei Li;Takashi Tanikawa;Ilona Kryczek;Houjun Xia

  • Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability

    Celina G. Kleer;Kenneth L. Van Golen;Yanhong Zhang;Zhi Fen Wu

  • Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants

    Celina G Kleer;Kenneth L van Golen;Sofia D Merajver

Frequent Co-Authors

Sofia D. Merajver
Sofia D. Merajver University of Michigan–Ann Arbor
Lisa A. Newman
Lisa A. Newman Cornell University
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
Max S. Wicha
Max S. Wicha University of Michigan–Ann Arbor
Arul M. Chinnaiyan
Arul M. Chinnaiyan University of Michigan–Ann Arbor
Kent A. Griffith
Kent A. Griffith University of Michigan–Ann Arbor
Sooryanarayana Varambally
Sooryanarayana Varambally University of Alabama at Birmingham
Alfred E. Chang
Alfred E. Chang University of Michigan–Ann Arbor
Lori J. Pierce
Lori J. Pierce University of Michigan–Ann Arbor
Jun Yao
Jun Yao The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to many related fields you can study online, often offering flexible schedules and lower costs. For those who prefer a pharmaceutical career, finding the best online pharmacy school can lead to opportunities in research, clinical settings, and drug development.

If you’re interested in the organization and management of healthcare data, rhit programs online provide training in health information management, coding, and patient privacy regulations. A related, in-demand field is medical billing. Completing a low cost medical coding and billing online program equips students for vital administrative roles in hospitals, clinics, and insurance companies.

Those focused on direct patient care might consider nurse practitioner programs, which combine advanced clinical training with leadership skills. These online pathways help aspiring professionals gain the necessary credentials to advance or specialize within the healthcare sector while accommodating busy lifestyles.

Best Scientists Citing Celina G. Kleer

Trending Scientists

Recently Published Articles